Continuous Glucose Monitoring (CGM)
Continuous Glucose Monitoring (CGM) is a medical device with 27 clinical trials. Currently 6 active trials ongoing. Historical success rate of 84.6%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.6%
11 of 14 finished
21.4%
3 ended early
6
trials recruiting
27
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and Obesity
Oral Anti Diabetic Agents in the Hospital
Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 Diabetes
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
Clinical Trials (27)
The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and Obesity
Oral Anti Diabetic Agents in the Hospital
Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 Diabetes
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
DP-DCT 1.0:A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform
Continuous Glucose Monitoring (CGM) in an Underserved Population
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study
IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)
Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus
Wearable Sensors and Artificial Intelligence for Carbohydrate Counting
Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial
Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis
Continuous Monitoring and Control of Hypoglycemia
Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 27